AbbVie

AbbVie is an American biopharmaceutical company headquartered in North Chicago, Illinois, formed in 2012 as a spin-off from Abbott Laboratories and publicly listed in January 2013. The company researches, develops, and commercializes a broad portfolio of medicines targeting immunology, oncology, neuroscience, eye care, aesthetics, and hepatitis C, with flagship products including Humira, Skyrizi, Rinvoq, Botox, Imbruvica, and Venclexta. AbbVie employs approximately 57,000 people and operates in more than 170 countries, generating $61.2 billion in revenue in 2025.